Umlobi: Mark Sanchez
Usuku Lokudalwa: 27 Ujanuwari 2021
Ukuvuselela Usuku: 1 Epreli 2025
Anonim
The Amazing Benefits of Berberine
Ividiyo: The Amazing Benefits of Berberine

-Delile

IBerberine yikhemikhali etholakala ezitshalweni eziningana ezibandakanya i-barberry yaseYurophu, i-goldenseal, i-goldthread, i-celandine enkulu, i-Oregon grape, i-phellodendron, ne-turmeric yesihlahla.

I-Berberine ivame ukuthathwa ngesifo sikashukela, amazinga aphezulu e-cholesterol noma amanye amafutha (lipids) egazini (hyperlipidemia), kanye nomfutho wegazi ophezulu. Ibuye isetshenziselwe ukusha, izilonda zesisu, isifo sesibindi, nezinye izimo eziningi kepha abukho ubufakazi obuhle besayensi obusekela okuningi kwalokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze UBERBERINE zimi kanje:

Kungenzeka kusebenze ...

  • Izilonda zekhankatha. Ucwaningo lukhombisa ukuthi ukufaka ijeli equkethe i-berberine kunganciphisa ubuhlungu, ukubomvu, ukuphuma, kanye nosayizi wezilonda kubantu abanezilonda zommbila.
  • Isifo sikashukela. IBerberine ibonakala inciphisa kancane amazinga kashukela egazini kubantu abanesifo sikashukela. Futhi, olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha ama-500 mg we-berberine ama-2-3 izikhathi nsuku zonke kuze kufike ezinyangeni ezintathu kungalawula ushukela wegazi ngempumelelo njenge-metformin noma i-rosiglitazone.
  • Izinga eliphakeme le-cholesterol noma amanye amafutha (lipids) egazini (hyperlipidemia). IBerberine ingasiza ekunciphiseni amazinga e-cholesterol kubantu abane-cholesterol ephezulu. Ukuthatha i-berberine kuze kube yiminyaka emibili kubonakala kunciphisa inani eliphelele le-cholesterol, i-low-density lipoprotein (LDL noma i- "bad") cholesterol, kanye namazinga e-triglyceride kubantu abane-cholesterol ephezulu. Uma iqhathaniswa nemithi ejwayelekile yokwehlisa i-cholesterol, i-berberine ibonakala idala ushintsho olufanayo ku-cholesterol ephelele, i-LDL cholesterol, ne-high-density lipoprotein (HDL noma "okuhle") cholesterol, futhi kungaba ngcono ekwehliseni amazinga e-triglyceride.
  • Umfutho wegazi ophezulu. Ukuthatha amagremu angu-0.9 we-berberine ngosuku kanye ne-blood pressure-ukwehlisa isidakamizwa i-amlodipine kunciphisa umfutho wegazi we-systolic (inombolo ephezulu) kanye ne-diastolic blood pressure (inombolo engezansi) kangcono kunokuthatha i-amlodipine yodwa kubantu abane-high blood pressure.
  • Isifo se-hormonal esibangela ama-ovari akhulisiwe ngama-cysts (i-polycystic ovary syndrome noma i-PCOS). Ucwaningo lukhombisa ukuthi i-berberine inganciphisa ushukela wegazi, ithuthukise amazinga e-cholesterol ne-triglyceride, yehlise amazinga e-testosterone, futhi yehlise isilinganiso sokhalo kuya okhalweni kwabesifazane abane-PCOS. IBerberine inganciphisa namazinga kashukela egazi ngokufanayo ne-metformin futhi ingahle ithuthukise amazinga e-cholesterol kangcono kune-metformin. Akucaci ukuthi i-berberine inyusa amazinga okukhulelwa noma amazinga okuzalwa aphilayo kwabesifazane abane-PCOS.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Kushe. Ucwaningo lwakuqala lukhombisa ukuthi ukusebenzisa umuthi oqukethe i-berberine ne-beta-sitosterol kungaphatha ukusha kwezinga lesibili ngempumelelo njengokwelashwa okuvamile nge-silver sulfadiazine.
  • Ukutheleleka kwamathumbu okubangela isifo sohudo (ikholera). Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine sulfate kunganciphisa isifo sohudo ngesilinganiso esincane kubantu abanekholera. Kodwa-ke, i-berberine ibonakala ingayithuthukisi imiphumela ye-tetracycline elwa namagciwane ekwelapheni isifo sohudo esihlobene nokutheleleka kwekholera.
  • Ukukhula okungewona umdlavuza emathunjini amakhulu naku-rectum (colorectal adenoma). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine iminyaka emi-2 kubonakala kuvimbela ukuvuseleleka kabusha kwe-adolovu e-colorectal kubantu asebevele belashelwa lokhu kukhula.
  • Ukwehluleka kwenhliziyo noketshezi kuyakha emzimbeni (ukuhluleka kwenhliziyo okucinana noma i-CHF). Ucwaningo lwakuqala lukhombisa ukuthi i-berberine inganciphisa ezinye zezimpawu futhi yehlise izinga lokufa kwabanye abantu abane-congestive heart failure.
  • Isifo senhliziyo. Ucwaningo lukhombisa ukuthi ukuthatha umkhiqizo othize oqukethe i-berberine nezinye izithako izinyanga ezintathu kwehlisa amazinga e-cholesterol kubantu abanesifo senhliziyo ababenenqubo ebizwa nge-percutaneous intervention (PCI). Lo mkhiqizo ubonakala wehlisa amazinga e-cholesterol ngaphezu kwemithi ejwayelekile ezetimibe, esetshenziselwa ukwehlisa i-cholesterol. Futhi ukuthatha lo mkhiqizo ngokuhambisana nemithamo ephansi yemithi ebizwa nge- "statins" kubonakala kusebenza kangcono kunokuthatha izitembu ezinomthamo ophansi uwedwa. Akucaci ukuthi imiphumela yalo mkhiqizo ingenxa ye-berberine, ezinye izithako, noma inhlanganisela. Akukaziwa nokuthi lo mkhiqizo uyayinciphisa yini ingozi yemicimbi emikhulu ehlobene nenhliziyo kubantu abanesifo senhliziyo.
  • Uhudo. Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine sulfate kunganciphisa isifo sohudo kubantu abane-E. coli infection.
  • Iqembu lokuphazamiseka kwamehlo okungaholela ekulahlekelweni kombono (glaucoma). Ucwaningo lwakuqala lukhombisa ukuthi ukusebenzisa amaconsi wamehlo aqukethe i-berberine ne-tetrahydrozoline akwehlisi ukucindezelwa kwamehlo kubantu abane-glaucoma kangcono kunamaconsi wamehlo aqukethe i-tetrahydrozoline kuphela.
  • Ukutheleleka kokugaya ukudla okungaholela ezilondeni (Helicobacter pylori noma H. ​​pylori). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine kusebenza kakhulu kunesidakamizwa i-ranitidine ekwelapheni ukutheleleka kwe-H. Pylori. Kepha i-berberine ibonakala ingasebenzi kangako ekwelapheni izilonda kubantu abanezilonda esiswini ngenxa kaH. Pylori. Olunye ucwaningo lukhombisa ukuthi i-berberine ingaphatha ukutheleleka kwe-H. Pylori kanye ne-bismuth yemithi lapho ithathwa ihambisana nomuthi ojwayelekile wezidakamizwa ezintathu ze-H. pylori ukutheleleka.
  • Ukuvuvukala (ukuvuvukala) kwesibindi okubangelwa igciwane le-hepatitis B (hepatitis B). Ucwaningo lwakuqala lukhombisa ukuthi i-berberine inciphisa ushukela wegazi, amafutha egazi abizwa nge-triglycerides, nezimpawu zokulimala kwesibindi kubantu abanesifo sikashukela kanye ne-hepatitis B.
  • Ukuvuvukala (ukuvuvukala) kwesibindi okubangelwa igciwane le-hepatitis C (hepatitis C). Ucwaningo lwakuqala lukhombisa ukuthi i-berberine inciphisa ushukela wegazi, amafutha egazi abizwa nge-triglycerides, nezimpawu zomonakalo wesibindi kubantu abanesifo sikashukela kanye ne-hepatitis C.
  • Ukuphazamiseka kwesikhathi eside kwamathumbu amakhulu okubangela ubuhlungu besisu (i-irritable bowel syndrome noma i-IBS). Ucwaningo lokuqala lubonisa ukuthatha i-berberine kabili nsuku zonke amasonto ayisishiyagalombili kunganciphisa isifo sohudo nobuhlungu besisu futhi kungathuthukisa ikhwalithi yempilo kubantu abane-IBS abanesifo sohudo.
  • Izimpawu zokunqamuka kokuya esikhathini. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha inhlanganisela ye-berberine ne-soy isoflavones kunganciphisa izimpawu ze-menopausal. Kodwa-ke, akucaci ukuthi i-berberine inciphisa izimpawu zokuya esikhathini uma isetshenziswa yodwa.
  • Ukuqoqwa kwezimpawu ezandisa ubungozi besifo sikashukela, isifo senhliziyo, nesifo sohlangothi (isifo se-metabolic syndrome). Ucwaningo lokuqala lukhombisa ukuthi i-berberine inciphisa inkomba yomzimba (BMI), umfutho wegazi we-systolic (inombolo ephezulu), amafutha egazi abizwa nge-triglycerides, kanye namazinga kashukela egazini kubantu abane-metabolic syndrome. Kubukeka futhi kuthuthukisa ukuzwela kwe-insulin. Olunye ucwaningo lwakuqala luphakamisa ukuthi ukuthatha umkhiqizo ohlanganisiwe oqukethe i-berberine, i-policosanol, irayisi ebomvu yemvubelo, i-folic acid, i-coenzyme Q10, ne-astaxanthin kuthuthukisa umfutho wegazi nokugeleza kwegazi kubantu abane-metabolic syndrome.
  • Yakha amafutha esibindini kubantu abaphuza utshwala obuncane noma abangaphuzi (isifo sesibindi esinamafutha noma i-NAFLD). Ucwaningo lokuqala lubonisa ukuthi i-berberine inciphisa amafutha egazini kanye nezimpawu zokulimala kwesibindi kubantu abanesifo sikashukela kanye ne-NAFLD. Olunye ucwaningo lwakuqala lukhombisa ukuthi i-berberine inganciphisa amafutha esibindini, izimpawu zokulimala kwesibindi, nesisindo kubantu abanalesi simo. I-Berberine ibonakala isebenza cishe kanjalo ne-pioglitazone yemithi.
  • Ukukhuluphala ngokweqile. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine kunganciphisa isisindo kubantu abakhuluphele cishe ngamakhilogremu ama-5.
  • Uhudo olubangelwa ukwelashwa ngemisebe. Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine ngesikhathi sokwelashwa ngemisebe kunganciphisa ukulimala kwamathumbu emisebeni ezigulini ezelashwa umdlavuza.
  • Ukuqubuka kwezicubu okubangelwa ukwelashwa ngemisebe. Olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine ngesikhathi sokwelashwa ngemisebe kunganciphisa ukulimala kwamaphaphu emisebeni yeziguli ezelashwa umdlavuza.
  • Izinga eliphansi lama-platelet egazini (i-thrombocytopenia). Ama-platelet egazi abalulekile ekunqandeni igazi. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine kungaba yedwa noma nge-prednisolone, kungakhuphula inani lamagazi egazi kubantu abanezibalo zegazi eliphansi.
  • Ukutheleleka kweso okubangelwa yiChlamydia trachomatis (trachoma). Kunobunye ubufakazi bokuthi amaconsi wamehlo aqukethe i-berberine angasiza ekwelapheni i-trachoma, imbangela ejwayelekile yobumpumputhe emazweni asathuthuka.
  • Uhlobo lwesifo samathumbu esivuthayo (ulcerative colitis). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-berberine akubonakali kuthuthukisa izimpawu kubantu abane-ulcerative colitis abathatha i-mesalamine yezidakamizwa.
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-berberine kulokhu kusetshenziswa.

IBerberine ingadala ukushaya kwenhliziyo okuqinile. Lokhu kungasiza abantu abanezimo ezithile zenhliziyo. IBerberine nayo ingasiza ekulawuleni ukuthi umzimba uwusebenzisa kanjani ushukela osegazini. Lokhu kungasiza abantu abanesifo sikashukela. Futhi ingakwazi ukubulala amagciwane futhi inciphise ukuvuvukala.

Lapho ithathwa ngomlomo: IBerberine OKUNGENZEKA UKUPHEPHA kubantu abadala abaningi ukusetshenziswa kwesikhashana. Imiphumela emibi ifaka phakathi isifo sohudo, ukuqunjelwa, igesi, ukucasuka kwesisu, nekhanda.

Lapho isetshenziswa esikhunjeni: IBerberine OKUNGENZEKA UKUPHEPHA kubantu abadala abaningi lapho besetshenziswa isikhathi esifushane.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Kunjalo Cishe UNGAPHEPHILE ukuthatha i-berberine ngomlomo uma ukhulelwe. Abaphenyi bakholelwa ukuthi i-berberine ingawela i-placenta futhi ingalimaza umbungu. I-Kernicterus, uhlobo lokulimala kobuchopho, isivele ezinganeni ezisanda kuzalwa ezichayeke ku-berberine.

Kubuye futhi Cishe UNGAPHEPHILE ukuthatha i-berberine uma uncelisa ibele. IBerberine ingadluliselwa enganeni ngobisi lwebele, futhi ingadala ingozi.

Izingane: Kunjalo Cishe UNGAPHEPHILE ukunikeza ama-berberine ezinganeni ezisanda kuzalwa. Kungadala i-kernicterus, uhlobo olungavamile lokulimala kobuchopho okungenzeka ezinganeni ezisanda kuzalwa ezine-jaundice ebucayi. I-jaundice iphuzi kwesikhumba okubangelwa yi-bilirubin eningi egazini. IBilirubin yikhemikhali elenziwa lapho amaseli amadala abomvu ewohloka. Imvamisa isuswa yisibindi. IBerberine ingagcina isibindi sisuse i-bilirubin ngokushesha okwanele. Alukho ulwazi olwanele oluthembekile lokwazi ukuthi i-berberine iphephile yini ezinganeni ezindala.

Isifo sikashukela: IBerberine inganciphisa ushukela wegazi. Ngokwethiyori, i-berberine ingadala ukuthi ushukela wegazi wehle kakhulu uma uthathwe ngabantu abanesifo sikashukela abalawula ushukela wegazi nge-insulin noma ngemithi. Sebenzisa ngokuqapha kubantu abanesifo sikashukela.

Izinga eliphezulu le-bilirubin egazini ezinganeni: IBilirubin yikhemikhali elenziwa lapho amaseli amadala abomvu egazi ehla. Imvamisa isuswa yisibindi. IBerberine ingagcina isibindi sisuse i-bilirubin ngokushesha okwanele. Lokhu kungadala izinkinga zobuchopho, ikakhulukazi ezinganeni ezinamazinga aphezulu we-bilirubin egazini. Gwema ukusebenzisa.

Umfutho wegazi ophansi: IBerberine yehlisa umfutho wegazi. Ngokwethiyori, i-berberine ingakhuphula ubungozi bokuthi umfutho wegazi ube ngaphansi kakhulu kubantu asebenengcindezi yegazi ephansi. Sebenzisa ngokuqapha.

Okukhulu
Ungathathi le nhlanganisela.
ICyclosporine (Neoral, Sandimmune)
Umzimba wephula i-cyclosporine ukuze uyiqede. IBerberine ingahle yehlise ukuthi umzimba wephula kanjani i-cyclosporine ngokushesha futhi ingahle yakheke emzimbeni futhi ingahle idale imiphumela emibi.
Maphakathi
Qaphela ngale nhlanganisela.
I-Dextromethorphan (i-Robitussin DM, abanye)
Umzimba wephula i-dextromethorphan ukuze uyiqede. IBerberine ingahle yehlise ukuthi umzimba uyihlephula ngokushesha kangakanani futhi ingakhuphula imiphumela kanye nemiphumela emibi ye-dextromethorphan.
I-Losartan (Cozaar)
Isibindi senza ilosartan isebenze. IBerberine inganciphisa ukuthi umzimba uyisebenzisa kanjani ngokushesha, futhi inganciphisa imiphumela yayo.
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2C9 (CYP2C9))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. IBerberine ingahle inciphise ukuthi isibindi siyiphula masinyane kanjani le mithi futhi sinyuse imiphumela yaso nemiphumela yaso emibi.

Eminye imithi eshintshwe yisibindi ifaka i-celecoxib (Celebrex), i-diclofenac (i-Voltaren), i-fluvastatin (i-Lescol), i-glipizide (i-Glucotrol), i-ibuprofen (i-Advil, i-Motrin), i-irbesartan (i-Avapro), i-losartan (i-Cozaar), i-phenytoin (i-Dilantin), i-piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), kanye no-S-warfarin (Coumadin).
Imithi ishintshwe yisibindi (iziqhekeza zeCytochrome P450 2D6 (CYP2D6))
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. IBerberine ingahle inciphise ukuthi isibindi siyiphula masinyane kanjani le mithi futhi sinyuse imiphumela yaso nemiphumela yaso emibi. Eminye imishanguzo eguqulwe isibindi ifaka i-amitriptyline (Elavil), i-codeine, i-desipramine (i-Norpramin), i-flecainide (i-Tambocor), i-haloperidol (i-Haldol), i-imipramine (i-Tofranil), i-metoprolol (i-Lopressor, i-Toprol XL), i-ondansetron (i-Zofran), i-paroxetine (i-Paxiletine) ), risperidone (Risperdal), tramadol (Ultram), venlafaxine (Effexor), nabanye.
Imithi ishintshwe yisibindi (ICytochrome P450 3A4 (CYP3A4)
Eminye imishanguzo iyashintshwa futhi yephulwe isibindi. IBerberine ingahle inciphise ukuthi isibindi siyiphula masinyane kanjani le mithi futhi sinyuse imiphumela yaso nemiphumela yaso emibi. Eminye imithi eshintshwe yisibindi ihlanganisa i-cyclosporin (Neoral, Sandimmune), lovastatin (Mevacor), i-clarithromycin (i-Biaxin), i-indinavir (i-Crixivan), i-sildenafil (i-Viagra), i-triazolam (i-Halcion), neminye eminingi.
Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)
IBerberine ingehlisa ushukela egazini. Imithi yesifo sikashukela nayo isetshenziselwa ukwehlisa ushukela egazini. Ukuthatha i-berberine kanye nemithi yesifo sikashukela kungadala ukuthi ushukela wegazi lakho wehle kakhulu. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imithi esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-Diabeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), neminye.
Imithi yokwelapha umfutho wegazi ophakeme (Imithi efuthayo)
IBerberine inganciphisa umfutho wegazi kwabanye abantu. Ukuthatha i-berberine kanye nemithi esetshenziselwa ukwehlisa umfutho wegazi ophezulu kungadala ukuthi umfutho wegazi lakho wehle kakhulu.

Eminye imishanguzo yomfutho wegazi ophakeme ihlanganisa i-captopril (Capoten), i-enalapril (i-Vasotec), i-losartan (i-Cozaar), i-valsartan (i-Diovan), i-diltiazem (i-Cardizem), i-amlodipine (i-Norvasc), i-hydrochlorothiazide (i-HydroDIURIL), i-furosemide (i-Lasix), neminye eminingi .
Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)
IBerberine inganciphisa ukuvimba kwegazi. Ukuthatha i-berberine kanye nemithi nayo ejija kancane ukuvimba kungandisa amathuba okulinyazwa nokopha.

Eminye imithi eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-cilostazol (i-Pletal), i-clopidogrel (i-Plavix), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox), i-heparin, i-ticlopidine (i-Ticlid), neminye.
I-Metformin (iGlucophage)
IBerberine ingakhuphula inani le-metformin emzimbeni. Lokhu kungakhuphula imiphumela yako kanye nemiphumela engemihle. Lokhu kusebenzisana kubonakala kwenzeka lapho i-berberine ithathwa cishe emahoreni amabili ngaphambi kwe-metformin. Ukuthatha i-berberine ne-metformin ngasikhathi sinye akubonakali kwandisa inani le-metformin emzimbeni.
I-Midazolam (Inamavesi)
Umzimba wephula i-midazolam ukuze uyiqede. IBerberine inganciphisa ukuthi umzimba uyichitha ngokushesha kangakanani futhi ingakhuphula imiphumela kanye nemiphumela emibi ye-midazolam.
I-Pentobarbital (Nembutal)
IPentobarbital ngumuthi ongadala ukulala. IBerberine nayo ingadala ukozela nokozela. Ukuthatha i-berberine nge-pentobarbital kungadala ubuthongo obukhulu.
Imithi yokudambisa (i-CNS depressants)
IBerberine ingadala ubuthongo nozela. Imithi ebanga ubuthongo ibizwa ngokuthi yimithi yokuthambisa. Ukuthatha i-berberine kanye nemithi yokwelapha kungadala ukulala kakhulu.

Eminye imishanguzo yokuthambisa ibandakanya i-benzodiazepines, i-pentobarbital (i-Nembutal), i-phenobarbital (i-Luminal), i-secobarbital (i-Seconal), i-thiopental (i-Pentothal), i-fentanyl (i-Duragesic, i-Sublimaze), i-morphine, i-propofol (i-Diprivan), neminye.
I-Tacrolimus (Prograf)
I-Tacrolimus yisidakamizwa sokuzivikela. Isuswa emzimbeni ngesibindi. IBerberine ingahle yehlise ukuthi umzimba uyisusa ngokushesha kangakanani futhi lokhu kungakhuphula imiphumela kanye nemiphumela emibi yetacrolimus.
Amakhambi nezengezo ezinganciphisa umfutho wegazi
IBerberine inganciphisa umfutho wegazi. Ukuyisebenzisa kanye namanye amakhambi nezengezo ezinomphumela ofanayo kungakhuphula ubungozi bokuthi umfutho wegazi wehle kakhulu kwabanye abantu. Eminye yale mikhiqizo ifaka i-andrographis, ama-casein peptides, uzipho lwekati, i-coenzyme Q-10, uwoyela wezinhlanzi, i-L-arginine, i-lycium, i-neting nettle, i-theanine, neminye.
Amakhambi nezithasiselo ezingehlisa ushukela egazini
IBerberine ingehlisa ushukela egazini. Ukuyisebenzisa kanye namanye amakhambi nezithako ezinomphumela ofanayo kungadala ukuthi ushukela wegazi wehle kakhulu kwabanye abantu. Eminye yale mikhiqizo ihlanganisa i-alpha-lipoic acid, ikhabe elibabayo, i-chromium, uzipho lukaSathane, i-fenugreek, i-garlic, i-guar gum, imbewu ye-chestnut yamahhashi, i-Panax ginseng, i-psyllium, i-ginseng yaseSiberia, neminye.
Amakhambi nezengezo ezinganciphisa ukujiya kwegazi
IBerberine inganciphisa ukuvimba kwegazi. Ukuthatha i-berberine kanye namanye amakhambi angahle anciphise ukuvalwa kwegazi kungakhuphula amathuba okulimala nokopha. Lawa makhambi afaka i-angelica, i-clove, i-danshen, i-garlic, i-ginger, i-ginkgo, i-Panax ginseng, namanye.
Amakhambi kanye nezithasiselo ezinezakhiwo zokuthambisa
IBerberine ingadala ukulala noma ukozela. Ukuyisebenzisa kanye namanye amakhambi nezithako ezinomphumela ofanayo kungakwenza ukozele ngokweqile. Amanye alawa makhambi nezithasiselo afaka i-calamus, i-poppy yaseCalifornia, i-catnip, i-hops, i-dogwood yaseJamaican, i-kava, i-L-tryptophan, i-melatonin, i-sage, i-SAMe, i-wort yaseSt.
Ama-Probiotic
Izithasiselo ze-Probiotic ziqukethe amabhaktheriya acatshangwa ukuthi ayinzuzo empilweni. IBerberine ingahle ibulale izinhlobo ezithile zama-probiotic. Uma ihlanganiswe ndawonye, ​​i-berberine inganciphisa ukuthi izithasiselo ze-probiotic zisebenza kanjani.
Akukho ukuxhumana okwaziwayo nokudla.
ABADALA

NGOMLOMO:
  • Okwesifo sikashukela: 0.9-1.5 amagremu eberberine athathwe ngemithamo ehlukanisiwe nsuku zonke izinyanga ezingama-2-4.
  • Ngamazinga aphezulu we-cholesterol noma amanye amafutha (lipids) egazini (hyperlipidemia): 0.6-1.5 amagremu eberberine athathwe ngemithamo ehlukanisiwe nsuku zonke izinyanga eziyisithupha kuya kweziyi-24. Imikhiqizo yenhlanganisela equkethe i-500 mg ye-berberine, i-10 mg ye-policosanol, ne-200 mg yelayisi elibomvu lemvubelo, kanye nezinye izithako, kuthathwe nsuku zonke kuze kube izinyanga eziyi-12.
  • Ngomfutho wegazi ophezulu: 0.9 amagremu eberberine athathwe nsuku zonke izinyanga ezimbili.
  • Ngokuphazamiseka kwehomoni okubangela ama-ovari akhulisiwe ngama-cysts (i-polycystic ovary syndrome noma i-PCOS): 1.5 amagremu eberberine athathwe nsuku zonke izinyanga ezi-3-6.
Kusetshenziswe esikhunjeni:
  • Ngezilonda ze-canker: Ijeli equkethe u-5 mg we-berberine ngegramu isetshenziswe kane ngosuku ngosuku izinsuku ezinhlanu.
I-Alcaloïde de Berbérine, Berberina, Berbérine, Berberine Alkaloid, Berberine Complex, Berberine Sulfate, Sulfate de Berbérine, Umbellatine.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. Asbaghi ​​O, Ghanbari N, Shekari M, et al. Umphumela we-berberine supplementation kumapharamitha wokukhuluphala, ukuvuvukala kanye nama-enzyme wokusebenza kwesibindi: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kwezilingo ezilawulwa ngokungahleliwe. Umtholampilo Wezempilo ESPEN 2020; 38: 43-9. Buka okungaqondakali.
  2. UChen YX, uGao QY, uZou TH, et al. I-Berberine kuqhathaniswa ne-placebo yokuvimbela ukuphindeka kwe-colorectal adenoma: i-multicentre, blinded blind, isifundo esilawulwa ngokungahleliwe. ILancet Gastroenterol Hepatol. 2020; 5: 267-75. Buka okungaqondakali.
  3. I-Beba M, i-Djafarian K, i-Shab-Bidar S. Umphumela we-Berberine kumaphrotheni asebenzayo e-C: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kwezilingo ezilawulwa ngokungahleliwe. Qedelela iTher Med. 2019; 46: 81-6. Buka okungaqondakali.
  4. ULyu Y, Zhang Y, Yang M, et al. Ukusebenzisana kwe-Pharmacokinetic phakathi kwe-metformin ne-berberine kumagundane: Indima yokulandelana kokuphathwa komlomo kanye ne-microbiota. Impilo Sci. 2019; 235: 116818. Buka okungaqondakali.
  5. UXu L, uZhang Y, Xue X, et al. Isivivinyo sesigaba sokuqala se-berberine ngesiShayina esine-ulcerative colitis. ICancer Prev Res (Phila). 2020; 13: 117-26. Buka okungaqondakali.
  6. UZhang LS, uZhang JH, uFeng R, et al. Ukusebenza nokuphepha kwe-berberine kuphela noma kuhlanganiswe nezimiso zokwelapha i-hyperlipidemia: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kokuhlolwa komtholampilo okulawulwa ngokungahleliwe. U-Am J Chin Med 2019; 47: 751-67. Buka okungaqondakali.
  7. I-Qing Y, i-Dong X, i-Hongli L, i-Yanhui L. Berberine ikhuthaze ukuvikelwa kwe-myocardial yeziguli zangemva kokuhlinzwa ngokulawula i-myocardial autophagy. I-Biomed Pharmacother. 2018; 105: 1050-1053. Buka okungaqondakali.
  8. UJu J, Li J, Lin Q, Xu H. Ukusebenza nokuphepha kwe-berberine ye-dyslipidaemias: Ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kokuhlolwa komtholampilo okungahleliwe. I-Phytomedicine. I-2018; 50: 25-34. Buka okungaqondakali.
  9. U-Li G, uZhao M, Qiu F, uSun Y, uZhao L.Ukusebenzisana kwe-Pharmacokinetic nokubekezelela i-berberine chloride nge-simvastatin ne-fenofibrate: isifundo esivulekile, esingahleliwe, esifanayo esifundweni se-Chinese esinempilo. Izidakamizwa Des Devel Ther. 2018; 13: 129-139. Buka okungaqondakali.
  10. UJan HM, Xia MF, uWang Y, uChang XX, uYao XZ, uRao SX, et al. Ukusebenza kwe-berberine ezigulini ezinesifo esingesona esinotshwala esinamafutha. Ama-PLoS One. 2015 Aug 7; 10: e0134172. i-doi: 10.1371 / journal.pone.0134172. Buka okungaqondakali.
  11. UChen C, uTao C, uLiu Z, uLu M, uPan Q, uZheng L, et al. Isivivinyo somtholampilo esingahleliwe se-berberine hydrochloride ezigulini ezinesifo sohudo-esivelele kakhulu esiswini. I-Phytother Res. 2015 Nov; 29: 1822-7. i-doi: 10.1002 / ptr.5475. Buka okungaqondakali.
  12. UWu XK, uWang YY, uLiu JP, uLiang RN, uXue HY, uMa HX, et al. Isivivinyo esilawulwa ngokungahleliwe se-letrozole, i-berberine, noma inhlanganisela yokungabi nenzalo ku-polycystic ovary syndrome. Umanyolo Oyinyumba. 2016; 106: 757-765.e1. i-doi: 10.1016 / j.fertnstert.2016.05.022. Buka okungaqondakali.
  13. UZhang D, Ke L, Ni Z, Chen Y, Zhang LH, Zhu SH, et al. I-Berberine equkethe ukwelashwa okune-quadruple kokuqedwa kokuqala kwe-Helicobacter pylori: Isivivinyo se-IV esivulekile esinelebuli evulekile. Imithi (iBaltimore). 2017; 96: e7697. i-doi: 10.1097 / MD.0000000000007697. Buka okungaqondakali.
  14. UMarazzi G, uCampolongo G, uPelliccia F, uQuattrino S, uVitale C, uCacciotti L, et al. Ukuqhathaniswa kwe-statin yedosi ephansi uma kuqhathaniswa ne-low-statin statin + i-Armolipid kanye neziguli eziphakeme ezingabekezeleleki ezinomcimbi owedlule we-coronary kanye ne-percutaneous coronary intervention (ADHERENCE trial). NginguJ Cardiol. 2017 Sep 15; 120: 893-897. i-doi: 10.1016 / j.amjcard.2017.06.015. Buka okungaqondakali.
  15. UMarazzi G, uPelliccia F, uCampolongo G, uQuattrino S, uCacciotti L, uVolterrani M, et al. Ukusebenziseka kwama-nutraceuticals (i-Armolipid Plus) uma kuqhathaniswa ne-ezetimibe nokuhlanganiswa kweziguli ezingabekezeleleki ezinesifo se-dyslipidemia esine-coronary heart disease. NginguJ Cardiol. 2015 Disemba 15; 116: 1798-801. i-doi: 10.1016 / j.amjcard.2015.09.023. Buka okungaqondakali.
  16. I-Wen C, i-Wu L, i-Fu L, i-Zhang X, i-Zhou H. Berberine ithuthukisa umsebenzi wokulwa nesimila we-tamoxifen kuma-MCF 7 abhekene nezidakamizwa namaseli we-MCF 7 / TAM amelana nemithi. I-Mol Med Rep. 2016; 14: 2250-6. Buka okungaqondakali.
  17. UMillán J, Cicero AF, Torres F, Anguera A. Imiphumela yenhlanganisela ye-nutraceutical equkethe i-berberine (BRB), i-policosanol, nelayisi elibomvu lemvubelo (i-RYR), kuphrofayela ye-lipid ezigulini ze-hypercholesterolemic: Ukuhlaziywa kwe-meta kokuhlolwa okungahleliwe. Umtholampilo Ophenyo Arterioscler. 2016; 28: 178-87. Buka okungaqondakali.
  18. UPérez-Rubio KG, uGonzález-Ortiz M, uMartínez-Abundis E, uRobles-Cervantes JA, u-Espinel-Bermúdez MC. Umphumela wokuphathwa kwe-berberine ku-metabolic syndrome, ukuzwela kwe-insulin, nokufihlwa kwe-insulin IMetab Syndr Relat Disord 2013; 11: 366-9. Buka okungaqondakali.
  19. ULan J, Zhao Y, Dong F, et al. Ukuhlaziywa kwe-meta komphumela nokuphepha kwe-berberine ekwelapheni uhlobo lwesifo sikashukela se-2, i-hyperlipemia ne-hypertension. J Ethnopharmacol. 2015; 161: 69-81. Buka okungaqondakali.
  20. UJiang XW, uZhang Y, uZhu YL, et al. Imiphumela ye-berberine gelatin ekuphindaphindeni kwe-aphthous stomatitis: isilingo esingahleliwe, esilawulwa yi-placebo, esiyimpumputhe kuqoqo lamaShayina. I-Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 115: 212-7. Buka okungaqondakali.
  21. IHou Q, uHan W, uFu X. Ukusebenzisana kwe-Pharmacokinetic phakathi kwe-tacrolimus ne-berberine enganeni ene-idiopathic nephrotic syndrome. I-Eur J Clin Pharmacol 2013; 69: 1861-2. Buka okungaqondakali.
  22. UDong H, Zhao Y, Zhao L, Lu F. Imiphumela ye-berberine kuma-lipids egazi: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta-kwezivivinyo ezilawulwa ngokungahleliwe. UPlanta Med 2013; 79: 437-46. Buka okungaqondakali.
  23. I-Y, Sun Z, Zhang Y, Liu B, Guan Y, Lu M. Ukusetshenziswa kwe-berberine kwabesifazane abane-polycystic ovary syndrome abelashwa i-IVF. I-Clin Endocrinol (Oxf) 2014; 80: 425-31. Buka okungaqondakali.
  24. U-Abascal K, Yarnell E. Ukuthuthuka kwakamuva kwemitholampilo nge-berberine. I-Altern Complement Ther 2010; 16: 281-7.
  25. Huang CG, Chu ZL, Wei SJ, Jiang H, Jiao BH. Umphumela we-berberine ku-arachidonic acid metabolism kuma-platelet onogwaja namaseli endothelial. I-Thromb Res 2002; 106 (4-5): 223-7. Buka okungaqondakali.
  26. IGarber AJ. Ama-agonists e-glucagon afana ne-peptide 1 receptor agonists: ukubuyekezwa kokusebenza kwawo nokubekezelelana kwawo. Ukunakekelwa yisifo sikashukela 2011; 34 Suppl 2: S279-84. Buka okungaqondakali.
  27. UCoughlan KA, uValentine RJ, uRuderman NB, uShaha AK. Ukwenza kusebenze i-AMPK: ilitshe lokwelapha lohlobo 2 sikashukela? Isifo Sikashukela Metab Syndr Obes 2014; 7: 241-53. Buka okungaqondakali.
  28. I-Butcher NJ, i-Minchin RF. I-Arylamine N-acetyltransferase 1: injongo yezidakamizwa yenoveli ekuthuthukiseni umdlavuza. I-Pharmacol Rev 2012; 64: 147-65. Buka okungaqondakali.
  29. URuscica M, uGomaraschi M, uMombelli G, uMacchi C, uBosisio R, uPazzucconi F, uPavanello C, uCalabresi L, u-Arnoldi A, uSirtori CR, uMagni P.Nutraceutical indlela yokulinganisa ubungozi be-cardiometabolic: imiphumela yokungahleliwe, okuyimpumputhe kanye ne-crossover engahleliwe. funda no-Armolipid Plus. J Clin Lipidol. 2014; 8: 61-8. Buka okungaqondakali.
  30. URabbani G. Mechanism kanye nokwelashwa kwesifo sohudo ngenxa yeVibrio cholerae kanye ne-Escherichia coli: izindima zezidakamizwa kanye ne-prostaglandins. I-Danish Medical Bulletin 1996; 43: 173-185.
  31. UKaneda Y, uTorii M, uTanaka T, no-al. Imiphumela ye-in vitro ye-berberine sulphate ekukhuleni nasekwakhiweni kwe-Entamoeba histolytica, Giardia lamblia neTrichomonas vaginalis. Ama-Annal weTropical Medicine neParasitology 1991; 85: 417-425.
  32. USaksena HC, uTomar VN, noSoangra MR. Ukusebenza kasawoti omusha weBerberine Uni-Berberine kusifo esiseMpumalanga. Umkhuba Wamanje Wezokwelapha 1970; 14: 247-252.
  33. I-Purohit SK, i-Kochar DK, i-Lal BB, no-al. Ukutshalwa kweLeishmania tropica kusuka ezimeni ezingalashwa nezelashwa zesifo saseMpumalanga. Ijenali YaseNdiya Yezempilo Yomphakathi 1982; 26: 34-37.
  34. USharma R, uJoshi CK, noGoyal RK. I-Berberine tannate kuhudo olubi. Ama-Pediatrics amaNdiya 1970; 7: 496-501.
  35. Li XB. [Isivivinyo somtholampilo esilawulwayo ezinganeni nasezinganeni eziqhathanisa ama-Lacteol Fort sachets nemithi emibili eyinkomba ye-antidiarrhoeal]. U-Ann Pediatr 1995; 42: 396-401.
  36. ULahiri S noDutta NK. I-Berberine ne-chloramphenicol ekwelapheni ikholera nohudo olunzima. Ijenali ye-Indian Medical Association 1967; 48: 1-11.
  37. IKamat SA. Ukuhlolwa kwemitholampilo nge-berberine hydrochloride yokulawula isifo sohudo ku-gastroenteritis ebukhali. J Assoc Odokotela eNdiya 1967; 15: 525-529.
  38. I-Dutta NK ne-Panse MV. Ukusetshenziswa kwe-berberine (i-alkaloid evela eBerberis aristata) ekwelapheni ikholera (yokulinga). I-Indian J Med Res 1962; 50: 732-736.
  39. Wu, S. N., Yu, H. S., Jan, C. R., Li, H. F., no Yu, C. L. Imiphumela yokuvimbela ye-berberine kuma-voltage- ne-calcium-activated potassium currents kumaseli we-myeloma womuntu. ILife Sci 1998; 62: 2283-2294. Buka okungaqondakali.
  40. U-Ozaki, Y., Suzuki, H., noSatake, M. [Ucwaningo lokuqhathanisa ngokuhlungwa kwe-berberine eplasma ngemuva kokuphathwa ngomlomo kokukhishwa kwe-coptidis rhizoma, kukhishwa amaseli ayo akhulile, nokusetshenziswa okuhlangene kwalokhu okukhishwayo kanye ne-glycyrrhizae radix ekhishwe kumagundane] . Yakugaku Zasshi 1993; 113: 63-69. Buka okungaqondakali.
  41. U-Hu, F. L. [Ukuqhathanisa i-asidi ne-Helicobacter pylori ku-ulcerogenesis yesifo sezilonda ze-duodenal]. Zhonghua Yi.Ingxoxo.Za Zhi. 1993; 73: 217-9, 253. Buka okungaqondakali.
  42. U-Arana, B. A., Navin, T. R., Arana, F. E., Berman, J. D., noRosenkaimer, F. Ukusebenza kwesifundo esifushane (izinsuku eziyi-10) se-high-dose meglumine antimonate noma ngaphandle kwe-interferon-gamma ekwelapheni i-leishmaniasis enqunyiwe eGuatemala. I-Clin Infect Dis 1994; 18: 381-384. Buka okungaqondakali.
  43. UChekalina, S. I., Umurzakova, R. Z., Saliev, K. K., no-Abdurakhmanov, T. R. [Umphumela we-berberine bisulfate ku-platelet hemostasis ezigulini ze-thrombocytopenia]. IGematologiia i Transfuziologiia 1994; 39: 33-35. Buka okungaqondakali.
  44. Ni, Y. X., Yang, J., noFan, S. [Ucwaningo lwezokwelapha nge-jiang tang san ekwelapheni iziguli ezinesifo sikashukela esingancikile ku-insulin]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1994; 14: 650-652. Buka okungaqondakali.
  45. Kuo, C. L., Chou, C. C., no-Yung, B. Y. Berberine izakhiwo kanye ne-DNA ku-apoptosis eyenziwe nge-berberine kumaseli we-leukemic HL-60. Umdlavuza Lett 7-13-1995; 93: 193-200. Buka okungaqondakali.
  46. UMiyazaki, H., Shirai, E., Ishibashi, M., Hosoi, K., Shibata, S., no-Iwanaga, M. Ubungako be-berberine chloride emchameni womuntu ngokusebenzisa ukuqashwa kwe-ion okukhethiwe kumodi yokuncipha kwensimu. I-Biomed.I-Mass Spectrom. 1978; 5: 559-565. Buka okungaqondakali.
  47. Babbar, O. P., Chhatwal, V. K., Ray, I. B., noMehra, M. K. Umphumela wamaconsi wamehlo e-berberine chloride ezigulini ezinhle ze-trachoma. I-Indian J Med Res. 1982; I-76 Suppl: 83-88. Buka okungaqondakali.
  48. Mahajan, V. M., Sharma, A., noRattan, A. Umsebenzi we-Antimycotic we-berberine sulphate: i-alkaloid evela emithini yomuthi waseNdiya. Sabouraudia. 1982; 20: 79-81. Buka okungaqondakali.
  49. UMohan, M., Pant, C. R., Angra, S. K., noMahajan, V. M. Berberine kutrachoma. (Isivivinyo somtholampilo). Indiya J Ophthalmol. 1982; 30: 69-75. Buka okungaqondakali.
  50. UTai, Y. H., Feser, J. F., Marnane, W. G., noDesjeux, J. F. Imiphumela ye-Antisecretory ye-berberine ku-ile ile. NginguJ J Physiol 1981; 241: G253-G258. Buka okungaqondakali.
  51. UChun YT, Yip TT, Lau KL, no-al. Ucwaningo lwamakhemikhali ngomphumela we-hypotensive we-berberine kumagundane. UGen Pharmac 1979; 10: 177-182. Buka okungaqondakali.
  52. UDesai, A. B., Shah, K. M., no-Shah, D. M. Berberine ekwelapheni isifo sohudo. Indian Pediatr. 1971; 8: 462-465. Buka okungaqondakali.
  53. Khin, Maung U., Myo, Khin, Nyunt, Nyunt Wai, Aye, Kyaw, noTin, U. Isivivinyo somtholampilo se-berberine kuhudo olunamanzi olunamandla. UBr. Med.J (Clin.Res.Ed) 12-7-1985; 291: 1601-1605. Buka okungaqondakali.
  54. Khin, Maung U., Myo, Khin, Nyunt, Nyunt Wai, noTin, U. Ukuhlolwa komtholampilo we-berberine ephezulu kanye ne-tetracycline ekholera. J Ihudo Dis Res. 1987; 5: 184-187. Buka okungaqondakali.
  55. UThumm, H. W. noTritschler, J. [Isenzo sikaBerberin-sehla ekucindezelekeni kwe-intraocular (IOP) (ukuhumusha kombhali)]. Klin.Monbl.Augenheilkd. 1977; 170: 119-123. Buka okungaqondakali.
  56. U-Albal, M. V., Jadhav, S., noChandorkar, A. G. Ukuhlolwa kwemitholampilo kwe-berberine kwizifo ze-mycotic. Indiya J Ophthalmol. 1986; 34: 91-92. Buka okungaqondakali.
  57. U-Wang, N., Feng, Y., Cheung, F., Chow, OY, Wang, X., Su, W., noTong, Y. Ucwaningo lokuqhathanisa ngesenzo se-hepatoprotective sebhere bile ne-Coptidis Rhizoma ekhishwe emanzini i-fibrosis yesibindi yokuhlola kumagundane. BMC.Complement Altern.Med 2012; 12: 239. Buka okungaqondakali.
  58. I-Pisciotta, L., Bellocchio, A., neBertolini, S. Iphilisi le-Nutraceutical eliqukethe i-berberine ne-ezetimibe ephethini ye-plasma lipid ezifundweni ze-hypercholesterolemic kanye nomphumela wayo wokungezelela ezigulini ezine-hypercholesterolemia yomndeni ekwelashweni okunciphise ukwehlisa i-cholesterol. I-Lipids Health Dis 2012; 11: 123. Buka okungaqondakali.
  59. UTrimarco, V., Cimmino, CS, Santoro, M., Pagnano, G., Manzi, MV, Piglia, A., Giudice, CA, De, Luca N., no-Izzo, R.I-Nutraceuticals yokulawulwa kwengcindezi yegazi ezigulini. nomfutho wegazi ophakeme ojwayelekile noma webanga 1. Ukucindezelwa Kwegazi Okuphezulu Cardiovasc. 9-1-2012; 19: 117-122. Buka okungaqondakali.
  60. UHayasaka, S., Kodama, T., no-Ohira, A. Imithi yendabuko yaseJapan (kampo) kanye nokwelashwa kwezifo ezinamehlo: ukubuyekeza. Ngingu-J Chin Med 2012; 40: 887-904. Buka okungaqondakali.
  61. UHermann, R. no-von, uRichter O. Ubufakazi bemitholampilo yezidakamizwa zamakhambi njengabenzi bokuxhumana kwezidakamizwa ze-pharmacokinetic. IPlanta Med 2012; 78: 1458-1477. Buka okungaqondakali.
  62. Hu, Y., Ehli, EA, Kittelsrud, J., Ronan, PJ, Munger, K., Downey, T., Bohlen, K., Callahan, L., Munson, V., Jahnke, M., Marshall, LL, Nelson, K., Huizenga, P., Hansen, R., Soundy, TJ, noDavies, umphumela owehlisayo we-GE Lipid we-berberine ezifundweni zabantu nakumagundane. I-Phytomedicine. 7-15-2012; 19: 861-867. Buka okungaqondakali.
  63. ICarlomagno, G., Pirozzi, C., Mercurio, V., Ruvolo, A., noFazio, S. Imiphumela yenhlanganisela ye-nutraceutical ekuvuseleleni kabusha i-ventricular kwesokunxele nasekusebenzeni kwe-vasoreactivity ezifundweni ezine-metabolic syndrome. I-Nutab Metab Cardiovasc. Dis 2012; 22: e13-e14. Buka okungaqondakali.
  64. UCianci, A., Cicero, A. F., Colacurci, N., Matarazzo, M. G., noDe, Leo, V. Umsebenzi wama-isoflavones ne-berberine kwizimpawu ze-vasomotor kanye nephrofayili ye-lipid kwabesifazane abaya esikhathini. I-Gynecol.Endocrinol. 2012; 28: 699-702. Buka okungaqondakali.
  65. Xie, X., Meng, X., Zhou, X., Shu, X., noKong, H. [Ucwaningo ngomphumela wokwelapha kanye noshintsho lwe-hemorrheology lwe-berberine ezigulini ezintsha ezitholakele ezine-type 2 yesifo sikashukela esihlanganisa isifo sesibindi esinamafutha angenalo utshwala].UZhongguo Zhong Yao Za Zhi 2011; 36: 3032-3035. Buka okungaqondakali.
  66. UMeng, S., Wang, L. S., Huang, Z. Q., Zhou, Q., Sun, Y. G., Cao, J. T., Li, Y. G., noWang, uC.Q. Berberine ulungisa ukuvuvukala kweziguli ezine-acute coronary syndrome kulandela ukungenelela kwe-coronary percutaneous. Umtholampilo Exp. Pharmacol Physiol 2012; 39: 406-411. Buka okungaqondakali.
  67. UKim, H. S., Kim, M. J., Kim, E. J., Yang, Y., Lee, M. S., noLim, J. S. Berberine-eyenziwe nge-activation ye-AMPK ivimbela amandla we-metastatic wamaseli we-melanoma ngokunciphisa umsebenzi we-ERK kanye ne-COX-2 protein expression. I-Biochem. I-Pharmacol 2-1-2012; 83: 385-394. Buka okungaqondakali.
  68. UMarazzi, G., Cacciotti, L., Pelliccia, F., Iaia, L., Volterrani, M., Caminiti, G., Sposato, B., Massaro, R., Grieco, F., noRosano, G. Imiphumela yesikhathi eside yama-nutraceuticals (i-berberine, irayisi ebomvu yemvubelo, i-policosanol) ezigulini ze-hypercholesterolemic esezikhulile. U-Adv. 2011; 28: 1105-1113. Buka okungaqondakali.
  69. Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., noGuan, Y. Ucwaningo lomtholampilo ngomphumela wesikhathi esifushane we-berberine ngokuqhathanisa ne-metformin kuzimpawu zemetabolic zabesifazane abane-polycystic ovary syndrome. U-Eur J Endocrinol. 2012; 166: 99-105. Buka okungaqondakali.
  70. UWang, Q., Zhang, M., Liang, B., Shirwany, N., Zhu, Y., noZou, MH Ukwenza kusebenze i-AMP-activated protein kinase iyadingeka ekwehlisweni kwe-berberine okubangelwa i-atherosclerosis kumagundane: indima we-protein engahluziwe 2. I-PLoS.One. 2011; 6: e25436. Buka okungaqondakali.
  71. UGuo, Y., Chen, Y., Tan, Z. R., Klaassen, C. D., noZhou, H. H. Ukuphathwa okuphindiwe kwe-berberine kuvimbela ama-cytochromes P450 ebantwini. I-Eur J Clin Pharmacol 2012; 68: 213-217. Buka okungaqondakali.
  72. IWundlu, JJ, Holick, MF, Lerman, RH, Konda, VR, Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, I-JS, ne-Tripp, i-ML Ukudla okunomsoco kwe-hop rho iso-alpha acids, i-berberine, i-vitamin D, ne-vitamin K ikhiqiza iphrofayli evumayo ye-bone biomarker esekela ukuphiliswa kwamathambo okunempilo kwabesifazane be-postmenopausal abane-syndrome ye-metabolic. I-Nut Res 2011; 31: 347-355. Buka okungaqondakali.
  73. Holick, MF, iWundlu, JJ, Lerman, RH, Konda, VR, Darland, G., Minich, DM, Desai, A., Chen, TC, Austin, M., Kornberg, J., Chang, JL, Hsi, A., Bland, JS, noTripp, ML Hop rho iso-alpha acids, i-berberine, i-vitamin D3 kanye ne-vitamin K1 iba nomthelela omuhle kuma-biomarkers we-bone turnover kwabesifazane be-postmenopausal esivivinyweni samaviki angu-14. J Bone Umvukuzi. I-Metab 2010; 28: 342-350. Buka okungaqondakali.
  74. UZhang, H., Wei, J., Xue, R., Wu, JD, Zhao, W., Wang, ZZ, Wang, SK, Zhou, ZX, Song, DQ, Wang, YM, Pan, HN, Kong, I-WJ, ne-Jiang, i-JD Berberine yehlisa i-glucose egazini kuhlobo lwe-2 lwe-diabetes mellitus iziguli ngokwandisa ukubonakaliswa kwe-insulin receptor. I-Metabolism 2010; 59: 285-292. Buka okungaqondakali.
  75. UWang, Y., Jia, X., Ghanam, K., Beaurepaire, C., Zidichouski, J., noMiller, uL.Berberine nezitshalo zezitshalo zivimbela ukumuncwa kwe-cholesterol kuma-hamsters. I-Atherosclerosis 2010; 209: 111-117. Buka okungaqondakali.
  76. Li, GH, Wang, DL, Hu, YD, Pu, P., Li, DZ, Wang, WD, Zhu, B., Hao, P., Wang, J., Xu, XQ, Wan, JQ, Zhou, I-YB, ne-Chen, i-ZT Berberine ivimbela i-radiation radiation ebukhali emathunjini omuntu onesifo se-radiotherapy esiswini. IMed Oncol. 2010; 27: 919-925. Buka okungaqondakali.
  77. I-Affuso, F., Ruvolo, A., Micillo, F., Sacca, L., neFazio, S. Imiphumela yenhlanganisela ye-nutraceutical (i-berberine, irayisi elibomvu lemvubelo kanye ne-policosanols) emazingeni e-lipid nokusebenza kwe-endothelial okungahleliwe, okungaboni kabili , isifundo esilawulwa yi-placebo. I-Nutab Metab Cardiovasc. Dis 2010; 20: 656-661. Buka okungaqondakali.
  78. Jeong, H. W., Hsu, K. C., Lee, J. W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S., noKim, J. B. Berberine bacindezela izimpendulo ezinamandla ngokusebenzisa i-AMPK isebenze kuma-macrophages. NginguJ J Physiol Endocrinol. IMetab 2009; 296: E955-E964. Buka okungaqondakali.
  79. UKim, WS, Lee, YS, Cha, SH, Jeong, HW, Choe, SS, Lee, MR, Oh, GT, Park, HS, Lee, KU, Lane, MD, noKim, uJB Berberine kuthuthukisa ukucwiliswa kwe-lipid ekukhuluphaleni ngokulawula umsebenzi ophakathi nendawo nomngcele we-AMPK. NginguJ J Physiol Endocrinol. IMetab 2009; 296: E812-E819. Buka okungaqondakali.
  80. ULu, SS, Yu, YL, Zhu, HJ, Liu, XD, Liu, L., Liu, YW, Wang, P., Xie, L., noWang, uGJ Berberine ukhuthaza i-peptide-1 efana ne-glucagon (1 - 7). I-36) i-amide secretion kumagundane wesifo sikashukela esenziwe nge-streptozotocin. UJ Endocrinol. 2009; 200: 159-165. Buka okungaqondakali.
  81. Liu, Y., Yu, H., Zhang, C., Cheng, Y., Hu, L., Meng, X., noZhao, Y. Imiphumela yokuvikela i-berberine ekulimaleni kwamaphaphu okubangelwa yimisebe nge-intercellular adhesion molecular- 1 nokuguqula ukukhula kwe-beta-1 ezigulini ezinomdlavuza wamaphaphu. Umdlavuza we-Eur J 2008; 44: 2425-2432. Buka okungaqondakali.
  82. I-Yang, Z., Shao, YC, Li, SJ, Qi, JL, Zhang, MJ, Hao, W., noJin, GZ Imithi ye-l-tetrahydropalmatine ikhulisa kakhulu ukulangazelela i-opiate futhi inyuse izinga lokuziyeka kubasebenzisi be-heroin: umshayeli funda. I-Acta Pharmacol Sin. 2008; 29: 781-788. Buka okungaqondakali.
  83. UZhou, JY, Zhou, SW, Zhang, KB, Tang, JL, Guang, LX, Ying, Y., Xu, Y., Zhang, L., noLi, DD Imiphumela engapheli ye-berberine egazini, isibindi se-glucolipid metabolism kanye Inkulumo ye-PPARs yesibindi kumagundane wesifo sikashukela we-hyperlipidemic. IBiol Pharm Bull. 2008; 31: 1169-1176. Buka okungaqondakali.
  84. Yin, J., Xing, H., no Ye, J. Ukusebenza kwe-berberine ezigulini ezine-type 2 yesifo sikashukela. I-Metabolism 2008; 57: 712-717. Buka okungaqondakali.
  85. UZhang, Y., Li, X., Zou, D., Liu, W., Yang, J., Zhu, N., Huo, L., Wang, M., Hong, J., Wu, P., URen, G., no-Ning, G. Ukwelashwa kohlobo lwesifo sikashukela kanye ne-dyslipidemia ngesitshalo semvelo se-alkaloid berberine. J Clin Endocrinol. IMetab 2008; 93: 2559-2565. Buka okungaqondakali.
  86. Xu, M. G., Wang, J. M., Chen, L., Wang, Y., Yang, Z., noTao, J. Berberine-okubangelwa ukugqugquzela ukujikeleza kwamaseli we-endothelial progenitor kuthuthukisa ukuqina komthambo omncane womuntu. UJ Hum. Hypertens 2008; 22: 389-393. Buka okungaqondakali.
  87. U-Xin, H. W., Wu, X., Li, Q., Yu, A. R., Zhong, M. Y., no-Liu, Y. Imiphumela ye-berberine kuma-pharmacokinetics we-cyclosporin A kumavolontiya anempilo. Izindlela Zokuthola.Exp.Clin Pharmacol 2006; 28: 25-29. Buka okungaqondakali.
  88. UMantena, S. K., Sharma, S. D., noKatiyar, S. K. Berberine, umkhiqizo wemvelo, ukhuthaza ukuboshwa komjikelezo weseli lesigaba se-G1 kanye ne-apptosis ethembele ku-3 e-cell prostate carcinoma cell. I-Mol Cancer Ther 2006; 5: 296-308. Buka okungaqondakali.
  89. U-Lin, C. C., Kao, S. T., Chen, G. W., Ho, H., no-Chung, J. G. Apoptosis wamangqamuzana wegazi we-HL-60 namaseli we-murine we-leukemia we-WEHI-3 amangqamuzana abangelwa yi-berberine ngokusebenzisa i-caspase-3. I-Anticancer Res 2006; 26 (1A): 227-242. Buka okungaqondakali.
  90. U-Lin, J. P., Yang, J. S., Lee, J. H., Hsieh, W. T., no-Chung, J. G. Berberine bafaka ukuboshwa komjikelezo weseli kanye ne-apoptosis kulayini womuntu wesisu se-carcinoma SNU-5. Umhlaba J Gastroenterol. 1-7-2006; 12: 21-28. Buka okungaqondakali.
  91. Inoue, K., Kulsum, U., Chowdhury, S. A., Fujisawa, S., Ishihara, M., Yokoe, I., noSakagami, H. Tumor oqondene ne-cytotoxicity nomsebenzi we-apoptosis-oheha ama-berberines. I-Anticancer Res 2005; 25 (6B): 4053-4059. Buka okungaqondakali.
  92. U-Lee, S., Lim, H. J., Park, H. Y., Lee, K. S., Park, J. H., noJang, Y. Berberine uvimbela i-rat vascular smooth muscle cell ukusabalala nokufuduka kwe-vitro futhi kuthuthukisa ukwakheka kwe-neointima ngemuva kokulimala kwebhaluni ku-vivo. IBerberine ithuthukisa ukwakheka kwe-neointima kumodeli yegundane. I-Atherosclerosis 2006; 186: 29-37. Buka okungaqondakali.
  93. Kuo, C. L., Chi, C. W., noLiu, T.Y. Ukushintshashintsha kwe-apoptosis nge-berberine ngokuvimbela ukubonakaliswa kwe-cyclooxygenase-2 kanye noMcl-1 kumaseli womdlavuza womlomo. KuVivo 2005; 19: 247-252. Buka okungaqondakali.
  94. Kong, W., Wei, J., Abidi, P., Lin, M., Inaba, S., Li, C., Wang, Y., Wang, Z., Si, S., Pan, H., UWang, S., Wu, J., Wang, Y., Li, Z., Liu, J., noJiang, uJD Berberine yisidakamizwa esehlisa i-cholesterol esisebenza ngendlela ehlukile ehlukile kuma-statins. UNat Med 2004; 10: 1344-1351. Buka okungaqondakali.
  95. UYount, G., Qian, Y., Moore, D., Basila, D., West, J., Aldape, K., Arvold, N., Shalev, N., noHaas-Kogan, D. Berberine uzwisa umuntu glioma, kepha hhayi amaseli ajwayelekile we-glial, kuma-radiation ion in vitro. J Exp Ther Oncol. 2004; 4: 137-143. Buka okungaqondakali.
  96. ULin, S., Tsai, S. C., Lee, C. C., Wang, B. W., Liou, J. Y., noShyu, K. G. Berberine uvimbela inkulumo ye-HIF-1alpha nge-proteolysis ethuthukisiwe. UMol Pharmacol 2004; 66: 612-619. Buka okungaqondakali.
  97. UNishida, S., Kikuichi, S., Yoshioka, S., Tsubaki, M., Fujii, Y., Matsuda, H., Kubo, M., no-Irimajiri, K. Ukwenziwa kwe-apoptosis kumaseli we-HL-60 aphathwe amakhambi okwelapha. NginguJ Jin Med 2003; 31: 551-562. Buka okungaqondakali.
  98. Iizuka, N., Oka, M., Yamamoto, K., Tangoku, A., Miyamoto, K., Miyamoto, T., Uchimura, S., Hamamoto, Y., no-Okita, K. Ukukhonjwa kokuvamile noma okuhlukile Izakhi zofuzo ezihlobene nemisebenzi ye-antitumor yemithi yokwelapha kanye nengxenye yayo enkulu yi-oligonucleotide microarray. I-Int J Cancer 11-20-2003; 107: 666-672. Buka okungaqondakali.
  99. UJantova, S., Cipak, L., Cernakova, M., noKost'alova, D. Umphumela we-berberine ekwandeni, kumjikelezo weseli naku-apoptosis kumaseli we-HeLa ne-L1210. UJ Pharm Pharmacol 2003; 55: 1143-1149. Buka okungaqondakali.
  100. Hong, Y., Hui, S. S., Chan, B.T, noHou, J. Umphumela we-berberine emazingeni e-catecholamine kumagundane ane-hypertrophy yenhliziyo yokuhlola. Impilo Sci. 4-18-2003; 72: 2499-2507. Buka okungaqondakali.
  101. UWang, DY, Yeh, CC, Lee, JH, Hung, CF, noChung, uJG Berberine uvimbele umsebenzi we-arylamine N-acetyltransferase nokukhuluma kofuzo nokwakheka kwe-DNA ekwenziweni kwe-astrocytoma ebulalayo yabantu (G9T / VGH) kanye nobuchopho be-glioblastoma multiforms (GBM 8401 amaseli. I-Neurochem. Res 2002; 27: 883-889. Buka okungaqondakali.
  102. ISriwilaijareon, N., Petmitr, S., Mutirangura, A., Ponglikitmongkol, M., neWilairat, P. Isigaba esithile sePlasmodium falciparum telomerase nokuvinjelwa kwayo yi-berberine. IParasitol. Int 2002; 51: 99-103. Buka okungaqondakali.
  103. I-Pan, J. F., Yu, C., Zhu, D. Y., Zhang, H., Zeng, J. F., Jiang, S. H., noRen, J. Y. Ukuhlonza ama-metabolites amathathu e-sulfate-ahlanganisiwe we-berberine chloride kumchamo wamavolontiya anempilo ngemuva kokuphathwa ngomlomo. I-Acta Pharmacol Sin. 2002; 23: 77-82. Buka okungaqondakali.
  104. USoffar, S. A., Metwali, D. M., Abdel-Aziz, S. S., el Wakil, H. S., noSaad, G. A. Ukuhlolwa komphumela we-alkaloid yesitshalo (i-berberine etholakala ku-Berberis aristata) ku-Trichomonas vaginalis in vitro. J IGibhithe.Soc Parasitol. 2001; 31: 893-904. Buka okungaqondakali.
  105. Inbaraj, J. J., Kukielczak, B. M., Bilski, P., Sandvik, S. L., noChignell, C. F. Photochemistry kanye ne-photocytotoxicity yama-alkaloid avela eGoldenseal (Hydrastis canadensis L.) 1. Berberine. IChem Res Toxicol 2001; 14: 1529-1534. Buka okungaqondakali.
  106. Wright, C.W, Marshall, S. J., Russell, P.F, Anderson, M. M., Phillipson, J. D., Kirby, G. C., Warhurst, D. C., kanye no-Schiff, P. L. UJ Nat Prod 2000; 63: 1638-1640. Buka okungaqondakali.
  107. U-Hu, J. P., Takahashi, N., no-Yamada, T. Coptidis rhizoma ivimbela ukukhula kanye nama-protease amabhaktheriya omlomo. I-Oral Dis. 2000; 6: 297-302. Buka okungaqondakali.
  108. UChung, JG, Chen, GW, Hung, CF, Lee, JH, Ho, CC, Ho, HC, Chang, HL, Lin, WC, noLin, JG Imiphumela ye-berberine emsebenzini we-arylamine N-acetyltransferase nomsebenzi we-2-aminofluorene- Ukwakhiwa kwe-DNA adduct kumaseli we-leukemia womuntu. NginguJ Jin Med 2000; 28: 227-238. Buka okungaqondakali.
  109. IBerberine. I-Altern Med Rev 2000; 5: 175-177. Buka okungaqondakali.
  110. Iizuka, N., Miyamoto, K., Okita, K., Tangoku, A., Hayashi, H., Yosino, S., Abe, T., Morioka, T., Hazama, S., no-Oka, M. Umphumela wokuvimbela weCoptidis Rhizoma ne-berberine ekwandeni kwemigqa yeseli yomdlavuza womuntu. Umdlavuza Lett 1-1-2000; 148: 19-25. Buka okungaqondakali.
  111. Chae, S.H, Jeong, I.H, Choi, D.H, Oh, J. W., no-Ahn, Y.J.Imiphumela yokuvimbela ukukhula kwama-alkaloid aseCoptis japonica asuselwa ezimpandeni kumagciwane wamathumbu womuntu. J Agric. Ukudla Chem 1999; 47: 934-938. Buka okungaqondakali.
  112. UZeng, X. noZeng, X. Ubudlelwano phakathi kwemiphumela yomtholampilo ye-berberine ekwehlulekeni okukhulu kwenhliziyo nokugxila kwayo ku-plasma okufundwe yi-HPLC. I-Biomed Chromatogr 1999; 13: 442-444. Buka okungaqondakali.
  113. U-Lin, J. G., Chung, J. G., Wu, L.T, Chen, G. W., Chang, H. L., no-Wang, T. F. Imiphumela ye-berberine ku-arylamine N-acetyltransferase emangqamuzaneni amathumba wesigaxa somuntu. NginguJ Jin Med 1999; 27: 265-275. Buka okungaqondakali.
  114. Chung, JG, Wu, LT, Chu, CB, Jan, JY, Ho, CC, Tsou, MF, Lu, HF, Chen, GW, Lin, JG, noWang, TF Imiphumela ye-berberine ku-arylamine N-acetyltransferase umsebenzi ku amangqamuzana wesisu sesinye somuntu. Ukudla Chem Toxicol 1999; 37: 319-326. Buka okungaqondakali.
  115. U-Wu, H. L., Hsu, C. Y., Liu, W. H., no-Yung, B. Y. I-Berberine eyenziwe nge-apoptosis ye-leukemia yabantu amaseli we-HL-60 ahlotshaniswa nokulawulwa phansi kwe-nucleophosmin / B23 nomsebenzi we-telomerase. I-Int J Cancer 6-11-1999; 81: 923-929. Buka okungaqondakali.
  116. I-Sun D, ​​i-Courtney HS, ne-Beachey EH. I-Berberine sulfate ivimba ukunamathela kwe-Streptococcus pyogenes kumaseli we-epithelial, i-fibronectin, ne-hexadecane. Ama-Antimicrobial Agents kanye neChemotherapy 1988; 32: 1370-1374.
  117. UPalasuntheram C, Iyer KS, de Silva LB, no-al. Umsebenzi we-antibacterial weCoscinium fenestratum Colebr ngokumelene neClostridium tetani. I-Ind J Med Res 1982; 76 (Suppl): 71-76.
  118. UZhu B no-Ahrens FA. Umphumela we-berberine ekusithekeni kwamathumbu okulamulelwe ngu-Escherichia coli enterotoxin ozinzile oshisa ngokushisa kwezingulube. NginguJ J Vet Res 1982; 43: 1594-1598.
  119. USupek Z noTomic D. Farmakološko-kemijsko istrazivanje zutike (
  120. UZalewski A, Krol R, noMaroko PR. IBerberine, i-ejenti entsha ye-inotropic - umehluko phakathi kwezimpendulo zayo zenhliziyo neziphathelene nomngcele. Umtholampilo Res 1983; 31: 227A.
  121. UKrol R, uZalewski A, noMaroko PR. Imiphumela ezuzisayo ye-berberine, i-ejenti entsha ye-inotropic enhle, kuma-arrhythmias we-digitalis-induced ventricular. Ukusatshalaliswa kwe-1982; 66 (suppl 2): ​​56.
  122. ISubbaiah TV no-Amin AH. Umphumela we-berberine sulphate ku-Entamoeba histolytica. Imvelo 1967; 215: 527-528.
  123. I-Kaneda Y, Tanaka T, ne-Saw T. Imiphumela ye-berberine, i-alkaloid yesitshalo, ekukhuleni kwe-anaerobic protozoa esikweni le-axenic. I-Tokai J Exp Clin Med 1990; 15: 417-423.
  124. UGhosh AK, Bhattacharyya FK, noGhosh DK. I-Leishmania donovani: ukuvinjelwa kwe-amastigote nemodi yesenzo se-berberine. Isivivinyo seParasitology 1985; 60: 404-413.
  125. USabir M, Mahajan VM, Mohapatra LN, no-al. Ucwaningo lokuhlola lwesenzo se-antitrachoma se-berberine. I-Indian J Med Res 1976; 64: 1160-1167.
  126. Seery TM futhi Bieter RN. Umnikelo ekhemisi ye-berberine. UJ Pharmacol Exp Ther 1940; 69: 64-67.
  127. ITripathi YB neShukla SD. IBerberis artistata ivimbela ukuhlanganiswa okubangelwe ngama-platelet onogwaja. Ucwaningo lwe-Phytotherapy 1996; 10: 628-630.
  128. USabir M noBhide NK. Ukufundwa kwezenzo ezithile zemithi ye-berberine. I-Ind J Physiol & Pharmac 1971; 15: 111-132.
  129. UChung JG, Wu LT, Chang SH, no-al. Izenzo zokuvimbela i-berberine ekukhuleni nomsebenzi we-arylamine N-acetyltransferase ezinhlotsheni ze-Helicobacter Pylori ezivela ezigulini ezinesilonda. Ijenali Yomhlaba Wonke Yezobuthi 1999; 18: 35.
  130. ISharda DC. I-Berberine ekwelapheni isifo sohudo ebuntwaneni nasebuntwaneni. J Indian M A 1970; 54: 22-24.
  131. UVik-Mo H, uFaria DB, uCheung WM, no-al. Imiphumela ezuzisayo ye-berberine ekusebenzeni kwe-ventricular kwesokunxele ezinjeni ezinokwehluleka kwenhliziyo. Ucwaningo Lwemitholampilo 1983; 31: 224a.
  132. UKsiezycka E, Cheung W, noMaroko PR. Imiphumela ye-antiarrhythmic ye-berberine kuma-aconitine abangelwa yi-ventricular kanye ne-supraventricular arrhythmias. Ucwaningo Lwemitholampilo 1983; 31: 197A.
  133. Seow WK, Ferrante A, Summors A, futhi et al. Imiphumela yokuqhathanisa i-tetrandrine ne-berbamine ekukhiqizeni ama-cytokines wokuvuvukala interleukin-1 ne-tumor necrosis factor. Isayensi Yezempilo 1992; 50: pl-53-pl-58.
  134. UPeng, W. H., Hsieh, M.T, noWu, C. R. Umphumela wokuphathwa kwesikhathi eside kwe-berberine ku-amopolia eyenziwe nge-scopolamine kumagundane. UJpn J Pharmacol 1997; 74: 261-266. Buka okungaqondakali.
  135. U-Wu, J. F. no-Liu, T. P. [Imiphumela ye-berberine kuma-platelet aggregation kanye namazinga e-plasma we-TXB2 ne-6-keto-PGF1 alpha kumagundane anokuvaleka komthambo wobuchopho ophakathi nendawo]. I-Yao Xue.Xue.Bao. 1995; 30: 98-102. Buka okungaqondakali.
  136. Yuan, J., Shen, X. Z., noZhu, X. S. [Umphumela we-berberine ngesikhathi sokuhamba samathumbu amancane omuntu]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 1994; 14: 718-720. Buka okungaqondakali.
  137. UMuller, K., Ziereis, K., noGawlik, I. I-antipsoriatic Mahonia aquifolium kanye nezakhi zayo ezisebenzayo; II. Umsebenzi we-antiproliferative ngokumelene nokukhula kweseli kwama-keratinocyte womuntu. UPlanta Med 1995; 61: 74-75. Buka okungaqondakali.
  138. USwabb, E. A., Tai, Y. H., noJordani, L. Ukubuyiselwa emuva kuketshezi lwe-cholera olwenziwe nge-toxin ku-rat ileum yi-luminal berberine. NginguJ J Physiol 1981; 241: G248-G252. Buka okungaqondakali.
  139. USack, R. B. noFroehlich, J. L. Berberine uvimbela impendulo eyimfihlo yamathumbu emathunjini eVibrio cholerae kanye ne-Escherichia coli enterotoxin. Igciwane Immun. 1982; 35: 471-475. Buka okungaqondakali.
  140. UZhu, B. no-Ahrens, F. Imiphumela ye-Antisecretory ye-berberine ene-morphine, i-clonidine, i-L- phenylephrine, i-yohimbine noma i-neostigmine ku-pig jejunum. I-Eur J Pharmacol 12-9-1983; 96 (1-2): 11-19. Buka okungaqondakali.
  141. UShanbhag, S. M., Kulkarni, H. J., noGaitonde, B. B. Izenzo zezemithi ze-berberine ohlelweni oluphakathi lwezinzwa. UJpn. J Pharmacol 1970; 20: 482-487. Buka okungaqondakali.
  142. UChoudhry, V. P., Sabir, M., noBhide, V. N. Berberine eGiardiasis. Indian Pediatr. Ngo-1972; 9: 143-146. Buka okungaqondakali.
  143. Kulkarni, S. K., Dandiya, P. C., noVarandani, N. L. Uphenyo lwezemithi lwe-berberine sulphate. I-Jpn. J Pharmacol. Ngo-1972; 22: 11-16. Buka okungaqondakali.
  144. UMarin-Neto, uJ. Umtholampilo Cardiol. 1988; 11: 253-260. Buka okungaqondakali.
  145. Ni, Y. X. [Umphumela wokwelapha i-berberine ezigulini ezingama-60 ezine-type II yesifo sikashukela kanye nocwaningo lokuhlola]. UZhong.Xi.Yi.Jie.He.Za Zhi.- Ijenali YaseChina Yezentuthuko Zanamuhla Emithini Yesintu 1988; 8: 711-3, 707. View abstract.
  146. UZhang, M. F. noShen, Y. Q. [Imiphumela ye-Antidiarrheal kanye ne-anti-inflammatory ye-berberine]. I-Zhongguo Yao Li Xue.Bao. 1989; 10: 174-176. Buka okungaqondakali.
  147. UShaffer, uJ. E. Umsebenzi we-Inotropic kanye ne-chronotropic we-berberine kwi-guinea pig atria ehlukanisiwe. UJ Cardiovasc Pharmacol 1985; 7: 307-315. Buka okungaqondakali.
  148. Huang, W. M., Wu, Z. D., noGan, Y. Q. [Imiphumela ye-berberine ku-ischemic ventricular arrhythmia]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 1989; 17: 300-1, 319. Buka okungaqondakali.
  149. Huang, W.[Ama-tachyarrhythmias e-Ventricular aphathwe nge-berberine]. Zhonghua Xin.Xue.Guan.Bing.Za Zhi. 1990; 18: 155-6, 190. Buka okungaqondakali.
  150. UHui, K. K., Yu, J. L., Chan, W. F., no-Tse, E. Ukusebenzisana kwe-berberine nama-platelet alpha 2 adrenoceptors. Impilo Sci. 1991; 49: 315-324. Buka okungaqondakali.
  151. UFreile, ML, Giannini, F., Pucci, G., Sturniolo, A., Rodero, L., Pucci, O., Balzareti, V., no-Enriz, umsebenzi we-RD wama-antimicrobial wezinto ezinamanzi kanye ne-berberine ehlukaniswe ne-Berberis heterophylla . I-Fitoterapia 2003; 74 (7-8): 702-705. Buka okungaqondakali.
  152. UKhin, uMaung U. noNwe, uNwe Wai. Umphumela we-berberine ku-enterotoxin-indased intestinal fluid ukuqongelela kumagundane. J Ihudo Dis Res 1992; 10: 201-204. Buka okungaqondakali.
  153. IHajnicka, V., Kost'alova, D., Svecova, D., Sochorova, R., Fuchsberger, N., noToth, J. Umphumela weMahonia aquifolium compounds esebenzayo ekukhiqizweni kwe-interleukin-8 kulayini weseli womuntu oyedwa we-THP -1. UPlanta Med 2002; 68: 266-268. Buka okungaqondakali.
  154. Lau, C.W, Yao, X. Q., Chen, Z. Y., Ko, W. H., noHuang, Y. Izenzo zenhliziyo zemithambo yegazi ye-berberine. ICardiovasc Izidakamizwa Rev 2001; 19: 234-244. Buka okungaqondakali.
  155. UMitani, N., Murakami, K., Yamaura, T., Ikeda, T., noSaiki, I. Umphumela wokuvimbela i-berberine ku-mediastinal lymph node metastasis ekhiqizwa ukufakwa kwe-orthotopic of Lewis lung carcinoma. Umdlavuza Lett. 4-10-2001; 165: 35-42. Buka okungaqondakali.
  156. UFukuda, K., Hibiya, Y., Mutoh, M., Koshiji, M., Akao, S., noFujiwara, H. Ukuvinjelwa ngu-berberine we-cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol. 1999; 66: 227-233. Buka okungaqondakali.
  157. Li, H., Miyahara, T., Tezuka, Y., Namba, T., Suzuki, T., Dowaki, R., Watanabe, M., Nemoto, N., Tonami, S., Seto, H., kanye neKadota, S. Umphumela wamafomula wekampo ekubuyiseleni amathambo ku-vitro naku-vivo. II. Ukutadisha okuningiliziwe kwe-berberine. I-Biol Pharm Bull 1999; 22: 391-396. Buka okungaqondakali.
  158. Abe, F., Nagafuji, S., Yamauchi, T., Okabe, H., Maki, J., Higo, H., Akahane, H., Aguilar, A., Jimenez-Estrada, M., noReyes- I-Chilpa, R. Izakhi ze-Trypanocidal ezitshalweni 1. Ukuhlolwa kwezitshalo ezithile zaseMexico ngomsebenzi wazo we-trypanocidal kanye nezakhi ezisebenzayo eGuaco, izimpande ze-Aristolochia taliscana. I-Biol Pharm Bull 2002; 25: 1188-1191. Buka okungaqondakali.
  159. UChatterjee P, uFranklin MR. I-cytochrome p450 yabantu yokuvimbela nokwakheka okuyinkimbinkimbi kwemetabolism phakathi kokukhishwa kwegolideenseal kanye nezinto zalo ze-methylenedioxyphenyl. Izidakamizwa ze-Metab Dispos 2003; 31: 1391-7. Buka okungaqondakali.
  160. IBudzinski JW, Foster BC, Vandenhoek S, Arnason JT. Ukuhlolwa kwe-in vitro kwe-cytochrome yomuntu i-P450 3A4 inhibition ngokukhishwa okukhethiwe kwamakhambi okuhweba kanye nokuthanjiswa. I-Phytomedicine 2000; 7: 273-82. Buka okungaqondakali.
  161. I-Huang XS, i-Yang GF, i-Pan YC. Umphumela we-berberin hydrochloride ekugxileni kwegazi kwe-cyclosporine A ezigulini ezifakwe inhliziyo. UZhongguo Zhong Xi Yi Jie He Za Zhi 2008; 28: 702-4. Buka okungaqondakali.
  162. UZhang Y, Li X, Zou D, et al. Ukwelashwa kohlobo lwesifo sikashukela kanye ne-dyslipidemia ngesitshalo semvelo i-alkaloid berberine. UJ Clin Endocrinol Metab 2008; 93: 2559-65. Buka okungaqondakali.
  163. I-Cicero, i-AF, i-Rovati LC, ne-Setnikar I. Imiphumela ye-Eulipidemic ye-berberine ilawulwa yodwa noma ihlangene namanye ama-ejenti okwehlisa i-cholesterol. Uphenyo lomtholampilo olungaboni. Arzneimittelforschung. 2007; 57: 26-30. Buka okungaqondakali.
  164. IVollekova A, uKost'alova D, uKettmann V, umsebenzi kaToth J. Antifungal wokukhishwa kweMahonia aquifolium kanye nama-alkaloid awo amakhulu. I-Phytother Res 2003; 17: 834-7. Buka okungaqondakali.
  165. UKim SH, uShin DS, u-Oh MN, et al. Ukuvinjelwa kweprotheyini engaphezulu yebhaktheriya ehlanganisa i-transpeptidase sortase nge-isoquinoline alkaloids. I-Biosci Biotechnol Biochem 2004; 68: 421-4 .. Buka okungaqondakali.
  166. Li B, Shang JC, Zhou QX. [Ukufundwa kwama-alkaloid aphelele avela ku-rhizoma coptis chinensis kuzilonda zesisu zokuhlola]. IChin J Integr Med 2005; 11: 217-21. Buka okungaqondakali.
  167. U-Ivanovska N, uPhilipov S. Funda ngesenzo sokulwa nokuvuvukala kwe-Berberis vulgaris impande ekhishwe, izingxenyana ze-alkaloid nama-alkaloid amsulwa. I-Int J Immunopharmacol 1996; 18: 553-61. Buka okungaqondakali.
  168. U-Ang ES, uLee ST, uGan CS, et al. Ukuhlolisiswa kwendima yokwelashwa okuhlukile ekuphathweni kwesilonda sokusha: isilingo esingahleliwe siqhathanisa umswakama oshisayo osobala obushubile nezindlela ezijwayelekile ekuphathweni kweziguli ezinokusha okuncane. IMedGenMed 2001; 3: 3. Buka okungaqondakali.
  169. I-Tsai PL, i-Tsai TH. Ukukhishwa kwe-hepatobiliary kwe-berberine. Izidakamizwa zeMetab Dispos 2004; 32: 405-12. . Buka okungaqondakali.
  170. I-Wu X, Li Q, Xin H, Yu A, Zhong M. Imiphumela ye-berberine ekugxileni kwegazi kwe-cyclosporin A kubamukeli abatshalwe kabusha kwezinso: isifundo somtholampilo nesokhemisi. I-Eur J Clin Pharmacol 2005; 61: 567-72. Buka okungaqondakali.
  171. UKhosla PG, uNeeraj VI, uGupta SK, et al. I-Berberine, umuthi ongaba khona we-trachoma. UMfu Int Trach Pathol Ocul Trop Subtrop Sante Publique 1992; 69: 147-65. Buka okungaqondakali.
  172. I-Hsiang CY, i-Wu SL, i-Cheng SE, i-Ho TY. Ukukhiqizwa kwe-Acetaldehyde okubangelwa i-interleukin-1beta kanye ne-tumor necrosis factor-alpha kukhiqizwa kuvinjelwe yi-berberine ngokusebenzisa i-nuclear factor-kappaB esayina indlela kumaseli we-HepG2. J Biomed Sci 2005; 12: 791-801. Buka okungaqondakali.
  173. U-Anis KV, uRajeshkumar NV, uKuttan R. Ukuvinjelwa kwamakhemikhali e-carcinogenesis yi-berberine kumagundane namagundane. UJ Pharm Pharmacol 2001; 53: 763-8. . Buka okungaqondakali.
  174. UZeng XH, uZeng XJ, Li YY. Ukusebenza nokuphepha kwe-berberine yokwehluleka kokuqina kwenhliziyo okulandelayo kuya kwe-ischemic noma idiopathic dilated cardiomyopathy. NginguJ J Cardiol 2003; 92: 173-6. Buka okungaqondakali.
  175. UJanbaz KH, uGilani AH. Ucwaningo ngemiphumela yokuvikela nokwelapha ye-berberine kwi-hepatotoxicity eyenziwe ngamakhemikhali kumagundane. UFitoterapia 2000; 71: 25-33 .. Buka okungaqondakali.
  176. UFukuda K, Hibiya Y, Mutoh M, et al. Ukuvinjelwa yi-berberine yomsebenzi we-cyclooxygenase-2 wokuloba kumaseli womdlavuza wamakholoni womuntu. UJ Ethnopharmacol 1999; 66: 227-33. Buka okungaqondakali.
  177. IPark KS, Kang KC, Kim JH, et al. Imiphumela eyehlukile yokuvimbela ama-protoberberines kuma-sterol kanye ne-chitin biosyntheses kuma-Candida albicans. J Imithi elwa namagciwane Chemother 1999; 43: 667-74. Buka okungaqondakali.
  178. UKim JS, uTanaka H, ​​uShoyama Y.Ukuhlaziywa kwe-immunoquantitative kwe-berberine kanye nama-compounds ayo ahlobene kusetshenziswa ama-antibody monoclonal emithini yemithi. Umhlaziyi 2004; 129: 87-91. Buka okungaqondakali.
  179. IScazzocchio F, iCorneta MF, uTomassini L, uPalmery M. Umsebenzi wama-antibacterial we-Hydrastis canadensis akhiphe kanye nama-alkaloid awo amakhulu angawodwa. UPlanta Med 2001; 67: 561-4. Buka okungaqondakali.
  180. I-Sun D, ​​i-Courtney HS, i-Beachey EH. I-Berberine sulfate ivimba ukunamathela kwe-Streptococcus pyogenes kumaseli we-epithelial, i-fibronectin, ne-hexadecane. Ama-Antimicrob Agents Chemother 1988; 32: 1370-4. Buka okungaqondakali.
  181. Amin AH, Subbaiah TV, Abbasi KM. I-Berberine sulfate: umsebenzi we-antimicrobial, bioassay, kanye nemodi yesenzo. Ingabe uJ Microbiol 1969; 15: 1067-76. Buka okungaqondakali.
  182. I-Bhide MB, i-Chavan SR, iDutta NK. Ukumuncwa, ukusatshalaliswa kanye nokukhishwa kwe-berberine. I-Indian J Med Res 1969; 57: 2128-31. Buka okungaqondakali.
  183. UChan E. Ukususwa kwe-bilirubin kusuka ku-albhamuin nge-berberine. I-Biol Neonate 1993; 63: 201-8. Buka okungaqondakali.
  184. I-Gupte S. Ukusetshenziswa kwe-berberine ekwelapheni i-giardiasis. Ngingu-J Dis Child 1975; 129: 866. Buka okungaqondakali.
  185. I-Kaneda Y, Torii M, Tanaka T, Aikawa M. In vitro imiphumela ye-berberine sulphate ekukhuleni nasekwakhiweni kwe-Entamoeba histolytica, Giardia lamblia neTrichomonas vaginalis. U-Ann Trop Med Parasitol 1991; 85: 417-25. Buka okungaqondakali.
  186. Ilanga D, Abraham SN, Beachey EH. Umthelela we-berberine sulfate ekuhlanganisweni nasekuvezeni i-ad fimbrial adhesin ku-uropathogenic Escherichia coli. Ama-Antimicrob Agents Chemother 1988; 32: 1274-7. Buka okungaqondakali.
  187. URehman J, uDillow JM, uCarter SM, et al. Ukukhiqizwa okwandisiwe kwama-antigen-specific immunoglobulins G no-M okulandela ukwelashwa kwe-vivo ngezitshalo zokwelapha i-Echinacea angustifolia ne-Hydrastis canadensis. I-Immunol Lett 1999; 68: 391-5. Buka okungaqondakali.
  188. USheng WD, uJiddawi MS, Hong XQ, u-Abdulla SM. Ukwelashwa komalaleveva omelana ne-chloroquine usebenzisa i-pyrimethamine ngokuhlangana ne-berberine, i-tetracycline, noma i-cotrimoxazole. EMpumalanga Afr Med J 1997; 74: 283-4. Buka okungaqondakali.
  189. URabbani GH, uButler T, uKnight J, et al. Isivivinyo esilawulwa ngokungahleliwe se-berberine sulphate therapy sohudo ngenxa ye-enterotoxigenic Escherichia coli neVibrio cholerae. J Ukutheleleka Dis 1987; 155: 979-84. Buka okungaqondakali.
  190. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
  191. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
  192. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Kugcine ukubuyekezwa - 01/26/2021

Ukushicilelwa

Ungayala Kanjani Ingane Eneminyaka Engu-2
Impilo

Ungayala Kanjani Ingane Eneminyaka Engu-2

Cabanga ngalokhu: U ekhaya, u ebenza etafuleni lakho. Indodakazi yakho eneminyaka emibili iza kuwe nencwadi eyithandayo. Ufuna umfundele. Umt hela kamnandi ukuthi awukwazi okwamanje, kodwa uzomfundela...
Ingabe Abantu AbaneBipolar Disorder Abanalo Uzwela?
Impilo

Ingabe Abantu AbaneBipolar Disorder Abanalo Uzwela?

Abaningi bethu banezikhathi ezinzima nezimbi. Kuyingxenye yempilo. Kepha abantu abane ifo okuphazami eka kwengqondo okuguquguqukayo babhekana nokuphakama nokwehla okwedlulele ngokwanele ukuphazami a u...